IRIS
CASTELLI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 717
AS - Asia 228
EU - Europa 121
AF - Africa 2
OC - Oceania 2
SA - Sud America 2
Totale 1.072
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 711
SG - Singapore 197
IT - Italia 71
CN - Cina 11
FI - Finlandia 8
CZ - Repubblica Ceca 7
SE - Svezia 7
DE - Germania 6
CA - Canada 5
KR - Corea 5
GB - Regno Unito 4
ES - Italia 3
FR - Francia 3
TR - Turchia 3
AU - Australia 2
BE - Belgio 2
HK - Hong Kong 2
IL - Israele 2
JP - Giappone 2
NL - Olanda 2
RS - Serbia 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
BR - Brasile 1
BS - Bahamas 1
DK - Danimarca 1
DZ - Algeria 1
ID - Indonesia 1
IE - Irlanda 1
IN - India 1
KZ - Kazakistan 1
LU - Lussemburgo 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 1.072
Salva come PNG Salva come JPEG
Città #
Chandler 229
Singapore 161
Princeton 140
New York 57
Milan 12
Santa Clara 8
Brno 7
Helsinki 7
Olbia 7
Sassari 7
Seoul 5
Frankfurt am Main 4
Lipari 4
San Francisco 4
Toronto 4
Boardman 3
San Mateo 3
Amsterdam 2
Ashburn 2
Belgrade 2
Brussels 2
Cormeilles-en-Parisis 2
Dallas 2
Edinburgh 2
Florence 2
Garbagnate Milanese 2
Hong Kong 2
Los Angeles 2
Madrid 2
Monserrato 2
Nuoro 2
Pasadena 2
Quartu Sant'Elena 2
Rome 2
Romola 2
Stockholm 2
Tel Aviv 2
Tokyo 2
Almaty 1
Arona 1
Bratislava 1
Brisbane 1
Buenos Aires 1
Copenhagen 1
Cornaredo 1
Dublin 1
Forest City 1
Ghardaïa 1
Guadalajara 1
Guiyang 1
Haikou 1
Harbin 1
Hyderabad 1
Johannesburg 1
Lappeenranta 1
Las Vegas 1
Laurel 1
Manila 1
Munich 1
Mīrpur 1
Nassau 1
Oklahoma City 1
Ottawa 1
Qingdao 1
Rio de Janeiro 1
SantAntioco 1
Sesto San Giovanni 1
Shenzhen 1
St Petersburg 1
Surabaya 1
Sydney 1
Tappahannock 1
Tukwila 1
Uta 1
Totale 740
Salva come PNG Salva come JPEG
Nome #
A Diagnostic of Acquired Hemophilia Following PD1/PDL1 Inhibitors in Advanced Melanoma: The Experience of Two Patients and a Literature Review 38
Angioedema due to acquired C1-inhibitor deficiency : a bridging condition between autoimmunity and lymphoproliferation 29
The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity 28
Clinical Characteristics and treatment outcome of an 86-year old patient with acute myeloid leukemia with acute promyelocytic - like morphology and uncommon RARA fusion variant 27
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants 27
Biosimilar epoetin alfa increases haemoglobin levels and brings cognitive and socio-relational benefits to elderly transfusion-dependent multiple myeloma patients: results from a pilot study 26
Does Outcome/Survival of Patients With Myelodysplastic Syndromes Should Be Predicted by Reduced Levels of ADAMTS-13? Results From a Pilot Study 26
Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients 26
Neutrophilic progression in a case of polycytemia vera mimicking chronic neutrophilic leukemia: clinical and molecular characterization 26
Incidence of Venous Thromboembolism in Multiple Myeloma Patients across Different Regimens: Role of Procoagulant Microparticles and Cytokine Release 26
High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation 25
Current and Emerging Treatment Options for Patients with Relapsed Myeloma 23
Abnormal Hemostatic Parameters and Risk of Thromboembolism Among Patients With COVID-19 Infection 22
Thromboembolic complications in malignant haematological disorders 22
Endocrine Side Effects in Patients Treated with Immune Checkpoint Inhibitors: A Narrative Review 21
Bendamustine and Rituximab, as First Line Treatment, in Intermediate, High Risk Splenic Marginal Zone Lymphomas of Elderly Patients 21
Cancer and thromboembolism: from biology to clinics 21
Aggressive natural killer cell leukaemia with a complex karyotype: a case report 21
Bendamustine in association with rituximab for first-line treatment of diffuse large B-cell lymphoma in frail patients ineligible for R-CHOP/R-CHOP-like treatments 21
Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management 20
Choosing treatment options for patients with relapsed/refractory multiple myeloma 20
Immunomodulatory drugs in multiple myeloma : from molecular mechanisms of action to clinical practice 20
Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate 20
The impact of an aging population on the diagnosis of pulmonary embolism: comparison of young and elderly patients 20
Ferric Carboxymaltose and Erythropoiesis-Stimulating Agent Treatment Reduces the Rate of Blood Transfusion in Refractory Anemia 19
Acquired C1-inhibitor deficiency and lymphoproliferative disorders : a tight relationship 19
Aggressive natural killer cell leukaemia with a complex karyotype: a case report 19
Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update 19
Aging of the Arterial System 19
Anti-t-PA antibodies in acute myocardial infarction after thrombolysis with rt-PA 18
High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibtor deficiency 18
Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects 18
Transmission of hepatitis G virus in patients with angioedema treated with steam-heated plasma concentrates of C1 inhibitor 18
Complement Activation in Patients With Immune Thrombocytopenic Purpura According to Phases of Disease Course 17
High rate of hepatitis B viral breakthrough in elderly non-Hodgkin lymphomas patients treated with Rituximab based chemotherapy 17
Hiv-Related Lymphoprolipherative Diseases In The Era Of Combination Antiretroviral Therapy 16
Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia 16
Management of anaemia in onco-haematological patients treated with biosimilar epoetin alfa: results of an Italian observational, retrospective study 16
First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas 16
Acquired Hemophilia A after SARS-CoV-2 Immunization: A Narrative Review of a Rare Side Effect 15
Concomitant use of Tyrosine-Kinase Inhibitor and Mepolizumab in Asthma Secondary to Chronic Myeloid Leukemia with Hypereosinophilia 15
Biosimilar epoetin in elderly patients with low risk myelodisplastic syndromes improves anaemia, quality of life and brain function 14
Midline peripheral catheters inserted in the superficial femoral vein at mid-thigh: Wise choice in COVID-19 acute hypoxemic respiratory failure patients with helmet continuous positive airway pressure 13
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis 12
Prothrombotic and inflammatory markers in elderly patients with non-alcoholic hepatic liver disease before and after weight loss: A pilot study 12
Possible Effect of Polycystic Ovary Syndrome (PCOS) on Cardiovascular Disease (CVD): An Update 10
High Rate of hepatitis B viral breakthrought in elderly non Hodgkin lymphomas patients treated with Rituximab based chemotherapy 10
Effect of hydroxyurea on extramedullary haematopoiesis in thalassaemia intermedia : case reports and literature review 10
Integrated short peripheral intravenous cannulas and risk of catheter failure: A systematic review and meta-analysis 9
Syncope in patients with pulmonary embolism: comparison between patients with syncope as the presenting symptom of pulmonary embolism and patients with pulmonary embolism without syncope 9
Immunomodulatory drugs : new options for the treatment of myelodysplastic syndromes 9
ADAMTS13, von Willebrand Factor, Platelet Microparticles, Factor VIII, and Impact of Somatic Mutations in the Pathogenesis of Splanchnic Vein Thrombosis Associated with BCR-ABL-Negative Myeloproliferative Neoplasms 9
Brachial Tunneled Peripherally Inserted Central Catheters and the Risk of Catheter Complications: A Systematic Review and Meta-Analysis 8
Platelet Microvesicles, Inflammation, and Coagulation Markers: A Pilot Study 8
Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies : from pathophysiology to the clinic 8
Interaction of C1 inhibitor with thrombin on the endothelial surface 8
Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Heart Failure: An Update 7
Pulmonary embolism in elderly patients: prognostic impact of the Cumulative Illness Rating Scale (CIRS) on short-term mortality 7
Unusual severe development of common B lymphoblastic leukemia in Gaucher disease type I 7
The value of four-detector row spiral computed tomography for the diagnosis of pulmonary embolism 7
The heparins and cancer: review of clinical trials and biological properties 7
Ibrutinib related bleeding complications in elderly patients with lymphoprolipherative disease 7
Intrathoracic masses due to extramedullary hematopoiesis 7
Laboratory and clinical risk assessment to treat myelodysplatic syndromes 6
The impact of anaemia, transfusion dependency, commorbidities and polypharmacy in elderly patients with low-risk myelodysplastic syndromes 6
Thrombosis and hemostatic Abnormalities in haematological malignancies 6
Inflammatory and prothrombotic parameters in normotensive non-diabetic obese women : effect of weight loss obtained by gastric banding 6
Successful management with intravenous immunoglobulins in alemtuzumab-induced acute inflammatory demyelinating neuropathy : clinical report of three patients 6
Rheumatoid factors : clinical applications 6
Personalized treatment strategies for elderly patients with myelodysplastic syndromes 6
Risk Of Thrombosis In Elderly Immune Primary Trombocytopenic Patients Treated With Thrombopoietin Receptors Agonists 6
Massive Right Atrial Thrombosis: Are You Brave Enough to Start Anticoagulation? A Case Report 5
Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation 5
Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical praticeguidelineupdate 5
Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency : clinical and molecular characterization 5
Risk-tailored treatment of splenic marginal zone lymphoma 5
Lymphoproliferative disease and acquired C1 inhibitor deficiency 4
Salvage therapy with bortezomib and dexamethasone in elderly patients with relapsed/refractory multiple myeloma 4
Unreliable estimation of HbA due to the presence of Camperdown haemoglobin [beta 104 (G6) Arg --> Ser] 4
New antithrobotic agents 4
Managment of anemia in low risk myelodysplastic syndromes treated with erythropoiesis-stimulating agents newer and older agents 4
Eltrombopag treatment for thrombocytopenia in myelodysplastic syndromes: differences between responding and non-responding patients—a pilot study 2
Totale 1.164
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.502
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.502
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022202 0 0 0 0 0 0 84 0 3 4 21 90
2022/2023516 70 0 2 85 50 77 0 85 96 8 25 18
2023/2024214 26 22 5 3 8 57 2 10 0 6 17 58
2024/2025232 10 13 85 24 100 0 0 0 0 0 0 0
Totale 1.164